Harnessing phytochemicals: Innovative strategies to enhance cancer immunotherapy
Drug Resistance Updates · 2025-03 · 79 · 101206
DOI: 10.1016/j.drup.2025.101206 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2025-03. Verfasst von Qianru Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China; State Key Laboratory of Quality Research in Chinese Medicines, Facu…. Hauptthemen laut MEDLINE: Neoplasms, Phytochemicals, Immunotherapy, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Cancer immunotherapy has revolutionized cancer treatment, but therapeutic ineffectiveness-driven by the tumor microenvironment and immune evasion mechanisms-continues to limit its clinical efficacy. This challenge underscores the need to explore innovative approaches, such as multimodal immunotherapy. Phytochemicals, bioactive compounds derived from plants, have emerged as promising candidates for overcoming these barriers due to their immunomodulatory and antitumor properties. This review explores the synergistic potential of phytochemicals in enhancing immunotherapy by modulating immune responses, reprogramming the tumor microenvironment, and reducing immunosuppressive factors. Integrating phytochemicals with conventional immunotherapy strategies represents a novel approach to mitigating resistance and enhancing therapeutic outcomes. For instance, nab-paclitaxel has shown the potential in overcoming resistance to immune checkpoint inhibitors, while QS-21 synergistically enhances the efficacy of tumor vaccines. Furthermore, we highlight recent advancements in leveraging nanotechnology to engineer phytochemicals for improved bioavailability and targeted delivery. These innovations hold great promise for optimizing the clinical application of phytochemicals. However, further large-scale clinical studies are crucial to fully integrate these compounds into immunotherapeutic regimens effectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China; State Key Laboratory of Quality Research in Chinese Medicines, Faculty of Chinese Medicine, Macau University of Science and Technology, M…
- School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.
- State Key Laboratory of Quality Research in Chinese Medicines, Faculty of Chinese Medicine, Macau University of Science and Technology, Macao.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhu, Q., Zhang, R., Zhao, Z., Xie, T., & Sui, X. (2025). Harnessing phytochemicals: Innovative strategies to enhance cancer immunotherapy. Drug Resistance Updates, 79, 101206. https://doi.org/10.1016/j.drup.2025.101206
Vancouver
Zhu Q, Zhang R, Zhao Z, Xie T, Sui X. Harnessing phytochemicals: Innovative strategies to enhance cancer immunotherapy. Drug Resistance Updates. 2025;79:101206. doi:10.1016/j.drup.2025.101206
BibTeX
@article{Zhu2025,
author = {Zhu, Qianru and Zhang, Ruonan and Zhao, Ziming and Xie, Tian and Sui, Xinbing},
title = {Harnessing phytochemicals: Innovative strategies to enhance cancer immunotherapy},
journal = {Drug Resistance Updates},
year = {2025},
volume = {79},
pages = {101206},
doi = {10.1016/j.drup.2025.101206}
}
EUVIMED